Dan Liang

1.6k total citations
73 papers, 1.1k citations indexed

About

Dan Liang is a scholar working on Ophthalmology, Molecular Biology and Immunology. According to data from OpenAlex, Dan Liang has authored 73 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Ophthalmology, 14 papers in Molecular Biology and 13 papers in Immunology. Recurrent topics in Dan Liang's work include Ocular Diseases and Behçet’s Syndrome (19 papers), Systemic Lupus Erythematosus Research (9 papers) and Retinal and Optic Conditions (7 papers). Dan Liang is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (19 papers), Systemic Lupus Erythematosus Research (9 papers) and Retinal and Optic Conditions (7 papers). Dan Liang collaborates with scholars based in China, United States and France. Dan Liang's co-authors include Wenru Su, Xiaohong Chen, Wenjie Zhu, Zhou Li-jun, Yi Zhu, Zhanrong Li, Jianfeng Yu, Nan Wang, Chengguo Zuo and Yimin Zhong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Biochemical and Biophysical Research Communications.

In The Last Decade

Dan Liang

66 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Liang China 18 260 198 195 142 109 73 1.1k
Diana V. Messadi United States 28 510 2.0× 61 0.3× 28 0.1× 58 0.4× 23 0.2× 55 2.0k
Wen Xu China 17 111 0.4× 68 0.3× 332 1.7× 157 1.1× 6 0.1× 93 871
Jensen Yeung Canada 21 125 0.5× 779 3.9× 48 0.2× 56 0.4× 5 0.0× 145 1.7k
Margaret H.L. Ng Hong Kong 19 597 2.3× 295 1.5× 14 0.1× 140 1.0× 14 0.1× 42 1.7k
Xinwei Zhang China 19 385 1.5× 239 1.2× 6 0.0× 64 0.5× 18 0.2× 113 1.7k
Chuan‐Hang Yu Taiwan 28 613 2.4× 76 0.4× 17 0.1× 42 0.3× 15 0.1× 89 1.8k
Qin Liu China 12 141 0.5× 55 0.3× 9 0.0× 29 0.2× 27 0.2× 52 781
Hsi‐Ming Lee United States 23 296 1.1× 221 1.1× 16 0.1× 113 0.8× 3 0.0× 44 1.8k
Wai‐Ching Lam Canada 31 411 1.6× 54 0.3× 1.8k 9.0× 140 1.0× 5 0.0× 131 2.6k
Amir Hossein Norooznezhad Iran 18 189 0.7× 111 0.6× 17 0.1× 73 0.5× 11 0.1× 57 931

Countries citing papers authored by Dan Liang

Since Specialization
Citations

This map shows the geographic impact of Dan Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Liang more than expected).

Fields of papers citing papers by Dan Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Liang. The network helps show where Dan Liang may publish in the future.

Co-authorship network of co-authors of Dan Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Liang. A scholar is included among the top collaborators of Dan Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Liang. Dan Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Wenjie, Guan‐Yu Chen, Zhuang Li, et al.. (2025). Circadian Rhythm Disruption Exacerbates Autoimmune Uveitis: The Essential Role of PER1 in Treg Cell Metabolic Support for Stability and Function. Advanced Science. 12(10). e2400004–e2400004.
2.
Huang, Haixiang, Yanyan Xie, Jing Zhong, et al.. (2024). Antimicrobial peptides loaded collagen nanosheets with enhanced antibacterial activity, corneal wound healing and M1 macrophage polarization in bacterial keratitis. Composites Part B Engineering. 275. 111283–111283. 16 indexed citations
3.
Chen, Mengting, Zhichao He, Jianhong Zhu, et al.. (2024). Hemorrhage profile associated with immune checkpoint inhibitors: a systematic review and a real-world study based on the FAERS database. Expert Opinion on Drug Safety. 23(4). 497–511. 3 indexed citations
4.
5.
Liang, Dan, et al.. (2024). Jin-Gui-Shen-Qi Wan alleviates fibrosis in mouse diabetic nephropathy via MHC class II. Journal of Ethnopharmacology. 324. 117745–117745. 8 indexed citations
6.
Yuan, Ping, et al.. (2024). Adalimumab Dose Reduction and Withdrawal in Stable Non-Infectious Pediatric Uveitis: An Open-Label, Prospective, Pilot Study. Ocular Immunology and Inflammation. 33(3). 332–339. 3 indexed citations
7.
Xie, Yanyan, Qian Chen, Yuxi Chen, et al.. (2023). Selective BD2 Inhibitor Exerts Anti-Fibrotic Effects via BRD4/FoxM1/Plk1 Axis in Orbital Fibroblasts From Patients With Thyroid Eye Disease. Investigative Ophthalmology & Visual Science. 64(7). 9–9. 6 indexed citations
8.
He, Zhichao, Jianhong Zhu, Dan Liang, et al.. (2023). Thromboembolism profiles associated with cyclin-dependent kinase 4/6 inhibitors: a real-world pharmacovigilance study and a systematic review. Expert Opinion on Drug Safety. 22(7). 599–609. 6 indexed citations
9.
Zhu, Jianhong, Dan Liang, Yayuan Zheng, et al.. (2022). Type 1 diabetes with immune checkpoint inhibitors: A systematic analysis of clinical trials and a pharmacovigilance study of postmarketing data. International Immunopharmacology. 110. 109053–109053. 5 indexed citations
10.
Wu, Junyan, Jianxiang Huang, Jianhong Zhu, et al.. (2022). Immune checkpoint inhibitors increase the risk of kidney transplant rejection: a real-world pharmacovigilance study. Expert Opinion on Drug Safety. 22(3). 231–235. 4 indexed citations
11.
He, Zhichao, Wenxia Zhao, Shan Yang, et al.. (2022). SGLT-2 inhibitors and euglycemic diabetic ketoacidosis/diabetic ketoacidosis in FAERS: a pharmacovigilance assessment. Acta Diabetologica. 60(3). 401–411. 18 indexed citations
12.
Wang, Ying, Dan Liang, Hua Zhu, et al.. (2020). Developing an Isotope Dilution UHPLC–MS/MS Method to Quantify Linezolid in Human Plasma: Application to Therapeutic Drug Monitoring. Bioanalysis. 12(14). 991–1001. 5 indexed citations
13.
Jiang, Zhaoxin, Ting Zhang, Xing Liu, et al.. (2020). Multimodal Imaging Features of Bilateral Choroidal Ganglioneuroma. Journal of Ophthalmology. 2020. 1–8. 2 indexed citations
14.
Zhu, Jianhong, Wenxia Zhao, Dan Liang, et al.. (2017). Risk of fatigue in cancer patients receiving anti-EGFR monoclonal antibodies: results from a systematic review and meta-analysis of randomized controlled trial. International Journal of Clinical Oncology. 23(2). 389–399. 1 indexed citations
15.
Yuan, Shuo, et al.. (2014). Simultaneous determination for the residue of thirteen pesticides in strawberry with solid phase extraction and gas chromatography.. Shipin anquan zhiliang jiance xuebao. 5(9). 2869–2876. 1 indexed citations
16.
Liang, Dan. (2013). Studies on Effective Part of Luffa Vine Extracts for Anti-inflammatory Action and Anti-allergic Action. Liaoning zhongyi zazhi. 1 indexed citations
17.
Liang, Dan. (2012). Research on Mathematics Anxiety of the Migrant Workers' Children in Junior Middle School——Come from Guilin Shiyou Middle School and Chuanshan Middle School. Journal on Mathematics Education.
18.
Wu, Junyan, et al.. (2009). Clinical observation of therapeutic effects with irbesartan and breviscapine on diabetic nephropa thy. Guoji yiyao weisheng daobao. 15(8). 53–55. 1 indexed citations
19.
Liang, Dan, et al.. (2009). AFLP-based sexual identification in Torreya grandis.. Zhejiang Linxueyuan xuebao. 26(1). 63–67. 1 indexed citations
20.
Liang, Dan, et al.. (2001). [Tissue interaction with bioglass ceramic implanted in the rabbit cornea].. PubMed. 17(4). 198–201. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diana V. Messadi Breakdown of academic impact, for papers by Wen Xu Breakdown of academic impact, for papers by Jensen Yeung Breakdown of academic impact, for papers by Margaret H.L. Ng Breakdown of academic impact, for papers by Xinwei Zhang Breakdown of academic impact, for papers by Chuan‐Hang Yu Breakdown of academic impact, for papers by Qin Liu Breakdown of academic impact, for papers by Hsi‐Ming Lee Breakdown of academic impact, for papers by Wai‐Ching Lam Breakdown of academic impact, for papers by Amir Hossein Norooznezhad
Rankless by CCL
2026